Publications by authors named "Iris Goetz"

Claim this Profile
A
Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study.
Chisom Kanu, Kristina S Boye, Jiat Ling Poon, Iris Goetz, Suzanne Williamson

Diabetes Obes Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial.
Iris A Goetz, Chisom Kanu, Anastasia Hoover, Cecilia Jimenez-Moreno, Hayley Karn

Obes Pillars· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric Validation of the Eating Behavior and Appetite Questionnaire (EBAQ) for Individuals with Obesity or Overweight.
Chisom Kanu, Miriam Kimel, Claudine Clucas, Iris Goetz, Lisa M Neff

Adv Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Content Evaluation of the Eating Behavior and Appetite Questionnaire (EBAQ) for Individuals with Obesity.
Chisom Kanu, Claudine Clucas, Anne Skalicky, Ashley Samuelson, Iris Goetz

Adv Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between patient-reported eating behaviours and weight change: Secondary analyses of a randomized, double-blind trial comparing retatrutide and placebo in people with obesity or overweight.
Chisom Kanu, Qiwei Wu, Jiat Ling Poon, Iris Goetz, Magaly Perez-Nieves

Diabetes Obes Metab· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evaluation of clinical outcomes assessments and digital health technologies in clinical trials for obesity.
Iris A Goetz, Carolyn Sutter, Traci Abraham, Chisom Kanu, Kristina S Boye

J Patient Rep Outcomes· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the GetReal Trial Tool - Facilitating discussion and understanding more pragmatic design choices and their implications.
Daniel Boateng, Thomas Kumke, Robin Vernooij, Iris Goetz, Anna-Katharina Meinecke

Contemp Clin Trials· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The GetReal Trial Tool: design, assess and discuss clinical drug trials in light of Real World Evidence generation.
Mira G P Zuidgeest, Iris Goetz, Anna-Katharina Meinecke, Daniel Boateng, Elaine A Irving

J Clin Epidemiol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a claims-based flare algorithm for systemic lupus erythematosus.
Iris Goetz, Casey Choong, Jennifer Winnie, David R Nelson, Julie Birt

Curr Med Res Opin· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.
Kristin J Meyers, Brian Dillman, Charles Williams, Jianfei Jiang, Nancy Clifford, Iris A Goetz

J Med Virol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of claims-based indicators used to identify flare-ups in inflammatory bowel disease.
Johan Burisch, He Zhang, Casey Kar-Chan Choong, David Nelson, April Naegeli, Iris Goetz

Therap Adv Gastroenterol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.
Kristin J Meyers, Meghan E Jones, Iris A Goetz, Fady T Botros, Jack Knorr

J Med Virol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world.
Paco M Welsing, Katrien Oude Rengerink, Sue Collier, Laurent Eckert, Maarten van Smeden, Iris Goetz

J Clin Epidemiol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Series: Pragmatic trials and real world evidence: Paper 4. Informed consent.
Shona Kalkman, Ghislaine J M W van Thiel, Mira G P Zuidgeest, Iris Goetz, Boris M Pfeiffer

J Clin Epidemiol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Series: Pragmatic trials and real world evidence: Paper 1. Introduction.
Mira G P Zuidgeest, Iris Goetz, Rolf H H Groenwold, Elaine Irving, Ghislaine J M W van Thiel

J Clin Epidemiol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRECIS-2 in perspective: what is next for pragmatic trials?
Mira G Zuidgeest, Iris Goetz, Diederick E Grobbee,

J Clin Epidemiol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Social Value of Pragmatic Trials.
Shona Kalkman, Ghislaine van Thiel, Rieke van der Graaf, Mira Zuidgeest, Iris Goetz

Bioethics· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmatic trial design elements showed a different impact on trial interpretation and feasibility than explanatory elements.
Joost B Nieuwenhuis, Elaine Irving, Katrien Oude Rengerink, Emily Lloyd, Iris Goetz

J Clin Epidemiol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive review of factors implicated in the heterogeneity of response in depression.
Gebra Cuyún Carter, Ronald A Cantrell, Victoria Zarotsky, Virginia S Haynes, Glenn Phillips, Iris Goetz

Depress Anxiety· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of treatment response in rheumatoid arthritis: assessment of heterogeneity.
Iris Goetz, Gebra Cuyún Carter, Melanie Lucero, Victoria Zarotsky, Carlos I Alatorre

Curr Med Res Opin· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability and treatment outcome of distinct classes of mania.
Inge van Rossum, Josep Maria Haro, Diederik Tenback, Maarten Boomsma, Iris Goetz

Eur Psychiatry· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
Eduard Vieta, Francesco Panicali, Iris Goetz, Catherine Reed, Merce Comes

J Affect Disord· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The social, psychopathological and consumer context of rate of symptom improvement in acute mania.
Jim van Os, Inge van Rossum, Maarten Boomsma, Eduard Vieta, Iris Goetz

Soc Psychiatry Psychiatr Epidemiol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy.
Cesario Bellantuono, Alessandra Barraco, Andrea Rossi, Iris Goetz

BMC Psychiatry· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voluntary vs. involuntary hospital admission in acute mania of bipolar disorder: results from the Swiss sample of the EMBLEM study.
Daniel Schuepbach, Iris Goetz, Heinz Boeker, Daniel Hell

J Affect Disord· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis